Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
TARSEQ : Essai de phase 2, randomisé, évaluant le docétaxel associé ou non à de l’erlotinib séquentiel, comme traitement de 2ème ligne, chez des patients ayant un cancer bronchique non à petites cellules en progression. [essai clos aux inclusions] https://www.kusajili.com:443/Trial/BZYfPk54VEeoR5HVnRZ2_Q%24tarseq-essai-de-phase-2-randomise-evaluant-le-docetaxel-associe-ou-non-a-de-lerlotinib-sequentiel-comme-traitement-de-2eme-lign
I have read and accept the terms of use of the site and the Privacy Policy
Send your message